Holen Sie sich die Stockscreener-App
3.42
11.17%
-0.43
Handel nachbörslich:
3.45
0.03
+0.88%
Schlusskurs vom Vortag:
$3.85
Offen:
$3.94
24-Stunden-Volumen:
4.46M
Relative Volume:
0.91
Marktkapitalisierung:
$421.52M
Einnahmen:
$4.21M
Nettoeinkommen (Verlust:
$-97.67M
KGV:
-3.6774
EPS:
-0.93
Netto-Cashflow:
$-70.76M
1W Leistung:
-23.58%
1M Leistung:
-7.57%
6M Leistung:
-14.29%
1J Leistung:
-37.36%
1-Tages-Spanne:
$3.37
$3.995
1-Wochen-Bereich:
$3.37
$4.415
52-Wochen-Spanne:
$2.45
$6.72
Absci Corp Stock (ABSI) Company Profile
Firmenname
Absci Corp
Sektor
Branche
Telefon
(360) 949-1041
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Vergleichen Sie ABSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
3.42 | 421.52M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-22 | Eingeleitet | Needham | Buy |
| 2024-10-02 | Eingeleitet | Guggenheim | Buy |
| 2024-07-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Eingeleitet | Truist | Buy |
| 2022-03-02 | Fortgesetzt | Cowen | Market Perform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-11-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | BofA Securities | Neutral |
| 2021-08-16 | Eingeleitet | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-16 | Eingeleitet | Stifel | Hold |
Alle ansehen
Absci Corp Aktie (ABSI) Neueste Nachrichten
Brokerages Set Absci Co. (NASDAQ:ABSI) Target Price at $8.57 - MarketBeat
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
Why Absci Corporation (ABSI) is Skyrocketing So Far in 2025 - Insider Monkey
Absci (NASDAQ:ABSI) Shares Down 11.3%Time to Sell? - MarketBeat
Absci (NASDAQ:ABSI) Stock Price Down 11.3%What's Next? - MarketBeat
Absci Co. (NASDAQ:ABSI) Stake Boosted by ARK Investment Management LLC - MarketBeat
Lowe’s Financial Results Beat On Top And Bottom Lines - Baystreet.ca
Absci (NASDAQ:ABSI) Shares Gap UpTime to Buy? - MarketBeat
Is Absci Corp. (ABSI) the Best Nasdaq Stock Under $5 to Buy? - MSN
Absci Co. (NASDAQ:ABSI) Short Interest Down 10.8% in January - MarketBeat
Absci to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
AI Drug Discovery Pioneer Absci Takes Center Stage at Major Healthcare ConferenceKey Innovations Unveiled - StockTitan
Absci (NASDAQ:ABSI) Stock Price Up 6.8%What's Next? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Increases Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Needham initiates Absci shares with Buy rating on strategy - MSN
Absci Target of Unusually High Options Trading (NASDAQ:ABSI) - MarketBeat
Absci (NASDAQ:ABSI) Trading Down 4.8%What's Next? - MarketBeat
SG Americas Securities LLC Acquires Shares of 42,222 Absci Co. (NASDAQ:ABSI) - Defense World
Vancouver biotech plans clinical trial of AI-developed drug - The Business Journals
10 Best Nasdaq Stocks Under $5 to Buy - Insider Monkey
Absci Corp (ABSI) Stock: A Year of Highs and Lows - The InvestChronicle
Investors Purchase Large Volume of Call Options on Absci (NASDAQ:ABSI) - Defense World
Analysts Set Absci Co. (NASDAQ:ABSI) Price Target at $8.57 - MarketBeat
An Analysis of Absci Corp (ABSI)’s Potential Price Growth - Knox Daily
Examining ABSI’s book value per share for the latest quarter - US Post News
Let’s Talk About Wall Street’s Projection For Absci Corp (NASDAQ: ABSI). - Marketing Sentinel
Two biotechs say they're using AI to conjure drugs from scratch. Their documents suggest otherwise - STAT
Absci (NASDAQ:ABSI) Shares Up 5.8%Time to Buy? - MarketBeat
ABSI Shares Experience Surge in Value - Knox Daily
ABSI Stock: Exploring Absci Corp’s Growth - The InvestChronicle
A significant driver of top-line growth: Absci Corp (ABSI) - SETE News
Short Interest in Absci Co. (NASDAQ:ABSI) Expands By 10.5% - MarketBeat
Analyzing the Price-to-Earnings Ratio of Absci Corp (ABSI) - The News Heater
ABSI’s price-to-free cash flow ratio: A closer look at its relevance - US Post News
Needham gives a Buy recommendation for Absci Corp (ABSI) - Knox Daily
Absci Co. (NASDAQ:ABSI) Shares Acquired by JPMorgan Chase & Co. - Defense World
Top 5 AI & Digital Biotech Companies (February 2025) - Securities.io
Absci Co. (NASDAQ:ABSI) Short Interest Update - Defense World
Peering Into Absci's Recent Short Interest - Benzinga
Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - MSN
Finanzdaten der Absci Corp-Aktie (ABSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Absci Corp-Aktie (ABSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | CFO / CBO |
Jun 13 '24 |
Sale |
4.98 |
19,859 |
98,892 |
384,751 |
| Phoenix Venture Partners II LP | 10% Owner |
May 22 '24 |
Sale |
4.40 |
3,100,000 |
13,640,000 |
11,279,522 |
6.45%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):